Lv1
64 积分 2025-03-24 加入
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
24天前
已完结
A Missing Link in Genotype-Directed Cancer Therapy
2个月前
已完结
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
2个月前
已完结
EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer
2个月前
已完结
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity
3个月前
已完结
Lung cancer
3个月前
已完结
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)]
3个月前
已完结
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
3个月前
已完结
Hydrogen bond analysis of the EGFR-ErbB3 heterodimer related to non-small cell lung cancer and drug resistance
3个月前
已关闭
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer
3个月前
已完结
皖公网安备34019202002308
